MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm14196843

Медицинская библиотека · Journal of clinical medicine · 2025

Hyperbaric Oxygen Therapy in the Management of Refractory Perianal Crohn's Disease.

Hajjar Roy, Bews Katherine A, Alaoui Ahmed Amine, Khan Sidrah, Gleason Lauren, Sanchez Emilio, Reynolds Ian S, Kane Sunanda V, Perry William R, Mathis Kellie L, McKenna Nicholas P

СтатьяПеревод в очереди

Аннотация

Background

Crohn's disease (CD) is an inflammatory bowel disease (IBD) that is prevalent worldwide. It can affect any segment of the gastrointestinal tract, from the mouth to the anus. When CD affects the anus, perianal fistulizing disease develops. The management of perianal CD is challenging and may require morbid surgery when there is no response to medical therapy. The emergence of novel biologic therapies, namely tumor necrosis alpha (TNF-α) inhibitors, has proven to provide long-term relief and prevent disease-related complications. Perianal CD is, however, refractory or recurrent in up to 80% of patients. One of the reported options to manage perianal CD is hyperbaric oxygen therapy (HBOT), which aims at increasing tissue oxygen saturation in an attempt to promote repair and reverse local inflammation. Data on this approach is scant.

Methods

A retrospective review was performed to identify patients with CD at the Mayo Clinic in Rochester who underwent HBOT for perianal disease between 2014 and 2023. Demographic and clinical data were reviewed, including the history of the disease, concomitant medical and surgical therapy and the need for fecal diversion. The HBOT regimen, including the number of sessions and clinical response, were reviewed.

Results

Six patients aged from 19 to 60 years underwent HBOT for perianal CD. Two patients had a history of total proctocolectomy with ileal-anal pouch anastomosis (IPAA). All patients except one were on immunosuppressive medication including biologic agents. Four patients had fecal diversion with an ileostomy or colostomy. Patients received between 10 and 40 sessions of HBOT. Four patients reported symptomatic improvement. On physical examination and/or imaging assessment, improvement was noted in one patient. Progression of the perianal disease was noted in all other patients, with all except one requiring an operation in the following year.

Conclusions

HBOT may provide symptomatic relief in some patients with refractory perianal CD, but data on its long-term efficacy remains limited.

Для цитирования: Hajjar Roy, Bews Katherine A, Alaoui Ahmed Amine, Khan Sidrah, Gleason Lauren, Sanchez Emilio, Reynolds Ian S, Kane Sunanda V, Perry William R, Mathis Kellie L, McKenna Nicholas P. Hyperbaric Oxygen Therapy in the Management of Refractory Perianal Crohn's Disease.. Journal of clinical medicine. 2025. DOI: 10.3390/jcm14196843.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.